COMMUNIQUÉS West-GlobeNewswire

-
Positive clinical phase III results of vortioxetine in Japanese adults with Major Depressive Disorder
08/06/2018 -
CALSTAR Air Medical Services to Open New Air Medical Base in Santa Cruz County
08/06/2018 -
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 41st European Cystic Fibrosis Conference (ECFS)
08/06/2018 -
Solon Eiendom ASA : Preliminary result of the subsequent offering
08/06/2018 -
Cannabis Wheaton Income Corp. Announces Name Change to Auxly Cannabis Group Inc.
08/06/2018 -
NHL player Max Domi teams up with thousands of Torontonians to walk to find a cure for type 1 diabetes
08/06/2018 -
Oncobiologics Closes Second Tranche of $15 Million Private Placement
08/06/2018 -
ADMA Biologics Announces Pricing of Public Offering of Common Stock
08/06/2018 -
Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
08/06/2018 -
Zealand Pharma achieves milestone in first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes
08/06/2018 -
Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
08/06/2018 -
Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
08/06/2018 -
Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
08/06/2018 -
GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cell Disease Research’s 12th Annual Symposium
08/06/2018 -
International Endeavors Corp Sales of OFF GRID GROW LAB (OGGL) continue to surpass expectations
08/06/2018 -
Sarepta Therapeutics to Host R&D Day on Tuesday, June 19, 2018
08/06/2018 -
Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
08/06/2018 -
Biohit Oyj: Managers' Transactions
08/06/2018 -
Biohit Oyj: Managers' Transactions
08/06/2018
Pages